Barchart.com
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
5.60 x 5 5.61 x 7
Post-market by (Cboe BZX)
6.03 +0.60 (+11.05%) 04/24/25 [NASDAQ]
5.60 x 5 5.61 x 7
Post-market 5.60 -0.43 (-7.13%) 19:29 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™ GlobeNewswire - Thu Apr 24, 6:30AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell Announces Four Clinical Data Presentations at ASCO 2025 GlobeNewswire - Wed Apr 23, 6:30AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC) GlobeNewswire - Tue Apr 22, 6:30AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer GlobeNewswire - Wed Apr 16, 6:30AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3 GlobeNewswire - Thu Apr 10, 7:00AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference GlobeNewswire - Wed Mar 26, 7:00AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer GlobeNewswire - Thu Mar 20, 7:00AM CDT

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
Author
Biotechs on the Brink: 2 Stocks With Huge Potential MarketBeat - Fri Feb 14, 6:15AM CST

BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.

DRUG : 33.42 (-1.99%)
BCTX : 6.03 (+11.05%)
RXRX : 5.75 (+3.05%)
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting GlobeNewswire - Wed Feb 5, 5:15PM CST

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)
BriaCell Therapeutics Announces Closing of Public Offering GlobeNewswire - Wed Feb 5, 3:05PM CST

BCT.TO : 8.45 (+10.60%)
BCTXW : 0.1706 (+13.81%)
BCTX : 6.03 (+11.05%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - 14 minutes ago
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot